image: TRPV4 inhibition reduces pulmonary edema. his image relates to a paper that appeared in the Nov. 7, 2012, issue of Science Translational Medicine, published by AAAS. The paper, by K.S. Thorneloe at GlaxoSmithKline in King of Prussia, Pa., and colleagues was titled, “An Orally Active TRPV4 Channel Blocker Prevents and Resolves Pulmonary Edema Induced by Heart Failure.” view more
Credit: Image courtesy of K. Thorneloe